Dermal Filler Market Thumbnail Image

2022

Dermal Filler Market

Dermal Filler Market Size, Share, Competitive Landscape and Trend Analysis Report by Type (Hyaluronic acid (HA), Calcium Hydroxylapatite (CaHA), Poly L lactic Acid, Others), by Gender (Male, Female), by Service Provider (Specialty and Dermatology Clinics, Hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Select an option
Author's: Linu Dash | Roshan Deshmukh
Publish Date:

Get Sample to Email

Dermal Filler Market Research, 2031

The global dermal filler market size was valued at $5,184.8 million in 2021, and is projected to reach $14,418.4 million by 2031, registering a CAGR of 10.8% from 2022 to 2031. Dermal fillers is defined as a minimally invasive aesthetic procedure which aims to temporarily fade fine lines, remove wrinkles, and soften the facial creases. It is a gel-like substance which is injected under the facial skin to add fullness and volume in skin and to achieve aesthetic outcome. The substance used in dermal fillers includes hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, polymethyl-methacrylate microspheres (PMMA). Some of the dermal filler applications are scar removal, restoration of lost volume, lip enhancement, facial line correction and wrinkle reduction.

Growth of the global dermal filler market size is majorly driven by rise in prevalence of early skin aging, and surge in demand for minimal invasive surgical procedure. In addition, increase in demand for dermal fillers procedure, increase in number of dermal filler industry to offer different dermal fillers products and rise in number of product approvals by different key players drive the dermal filler market growth. For instance, in February 2022, Merz Aesthetics, a medical aesthetics company, announced the launch of Radiesse (+) Lidocaine injectable implant for deep injection to improve moderate to severe loss of jawline contour in adults over the age of 21. Moreover, in May 2020, Galderma, a dermatology and pharmaceutical company, announced the U.S Food & Drug Administration (FDA) approval for restylane kysse, which is a new hyaluronic acid filler specifically designed and indicated to add fullness to lips and help smoothen wrinkles above the mouth.

Dermal Filler Market

The increase in number of geriatric population, surge the demand for dermal filler procedure and propel the growth of the market. For instance, in 2020, according to a report shared by American Society of Plastic Surgeons, in the U.S. approximately 3.2 million minimally invasive aesthetic procedures were performed in the age group of 55 to 69 years.

In addition, technological advancement in medical aesthetic products propels the market growth. Moreover, increase in self-awareness among young population regarding physical appearance propels the demand for facial aesthetics treatment. According to McKinsey and Company, in 2021, it was reported that social-media coverage of dermal fillers and biostimulators grew eightfold from 2010 to 2020. For instance, in 2022, Empire Medical Training (EMT), conduct a hand on dermal filler training session. The learners will understand how to use dermal filler procedure for various cosmetic indication. In addition, increase in sedentary lifestyle, further led to early aging, making them conscious about their appearance, which increases the need for dermal fillers procedure. For instance, Botulinum toxin aims to reduce facial fine lines and wrinkles, and encourages young population to go for such kind of facial aesthetic procedure. Moreover, facial aesthetics are used in a wide range of applications such as lip enhancement, restoration of facial volume and face rejuvenation, which surge the need for dermal fillers products. In addition,

However, high costs associated with dermal filler procedure such as fat face, and polymethyl-methacrylate microspheres are anticipated to limit adoption of the procedure during the forecast period. For instance, according to the American Society of plastic surgeons, the average cost of polymethyl-methacrylate microspheres is $1,058. Moreover, as per the same source, it was also reported that average cost of fat face procedure is around $2,508. Thus, this factor is anticipated to hinder the market growth.

Dermal Fillers Market Segmentation

The dermal filler market share is segmented on the basis of type, gender, service provider, and region. On the basis of type, the market is segmented into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly-L-lactic acid, and others. The others include polymethyl-methacrylate microspheres (PMMA), and fat face. By gender, the market is bifurcated into male, and female. By service provider, the market is classified into specialty & dermatology clinics, hospitals, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment Review

Dermal Fillers Market by Type

By type, the hyaluronic acid (HA) segment generated the highest revenue in the dermal fillers  market in 2021 owing to increase in adoption of dermal fillers by all age groups and rise in awareness about advantages of non-invasive aesthetic procedure among population. On the other hand, botulinum toxin segment is expected to witness considerable market growth during the dermal filler market forecast period, owing to increase in R&D activities in medical aesthetic sector and growth in number of therapeutic and aesthetic indication of botulinum toxin.

Dermal Filler Market by Type

Dermal Fillers Market by Gender

By gender, the female segment generated the highest revenue in the dermal fillers market in 2021, owing to increase in number of female geriatric population and rise in demand for correction of facial line among female population. On the other hand, male segment is expected to witness considerable market growth during the forecast period, owing to increase in the awareness in male population regarding availability of anti-aging treatment.

Dermal Filler Market by Gender

Dermal Fillers Market by Service Provider

By end user, the hospitals segment generated the highest revenue in the dermal fillers market in 2021, owing to increase in number of hospitals to conduct various facial aesthetic procedure, and rise in expenditure by governments to improve the healthcare industry. Ambulatory surgical centers is expected to register fastest CAGR during the forecast period, owing to rise in the prevalence of skin condition such as hyperpigmentation, acne, scars, stretch marks and increase in the number of professionals who provide treatment of facial aesthetics in dermatology clinics.

Dermal Filler Market by Service Provider

Dermal Fillers Market by Regions

North America accounted for the largest dermal filler market share in 2021 and is expected to retain its dominance throughout the forecast period. This is primarily attributed to rise in number of hyaluronic acid procedures, increase in number of approvals for dermal fillers products, presence of dermal filler industry, and advancements in medical aesthetic sector in the region. Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period, owing to increase in number of geriatric female populations, rise in awareness among young population regarding aesthetics, and growth in healthcare expenditures.

Dermal Filler Market by Region

Some of the major companies that operate in the global dermal fillers market include AbbVie Laboratories, Bioxis pharmaceutical, Cutera Inc., Elan aesthetics Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics, Sinclair Pharma, Teoxane Laboratories, and Vital Esthetique Laboratories

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the dermal filler market analysis from 2021 to 2031 to identify the prevailing dermal filler market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the dermal filler market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global dermal filler market trends, key players, market segments, application areas, and market growth strategies.

Dermal Filler Market Report Highlights

Aspects Details
Market Size By 2031
Market Size By 2031

USD 14.4 billion

Growth Rate
Growth Rate

CAGR of 10.8%

Forecast period
Forecast period

2021 - 2031

Report Pages
Report Pages

250

Dermal Filler Market By Type
By Type
  • Hyaluronic acid (HA)
    • Age group
      • 13 to 39
      • 40 to 54
      • 55 to 69
  • Calcium Hydroxylapatite (CaHA)
  • Poly L lactic Acid
  • Others
Dermal Filler Market By Gender
By Gender
  • Male
  • Female
Dermal Filler Market By Service Provider
By Service Provider
  • Specialty and Dermatology Clinics
  • Hospitals
  • Others
Dermal Filler Market By Region
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest Of Europe)
  • Asia-Pacific  (China, Japan, India, Australia, Rest Of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, Colombia, Rest Of LAMEA)
Key Market Players
Key Market Players

Sinclair Pharma, Elan aesthetics Inc, Bioxis pharmaceutical, Teoxane Laboratories, Vital Esthetique Laboratories, Revance Therapeutics, Merz Pharma GmbH and Co. KGaA, Cutera Inc, Galderma SA, AbbVie Laboratories

Analyst Review

This section provides opinions of the top-level CXOs operating in the dermal filler market. Dermal filler is defined as a substance, which is designed to be injected under the surface of the skin in order to add fullness and volume. Rise in awareness regarding effectiveness of facial aesthetic procedure among the population fuels the market growth. Moreover, increase in product launch by different key players boosts the dermal filler market.

In February 2022, AbbVie, a pharmaceutical company, announced the FDA approval of JUVÉDERM VOLBELLA XC, which is the first dermal filler used for the treatment of infraorbital hollows. Moreover, in 2022, Merz, a medical aesthetic company, announced the launch of Radiesse (+) Lidocaine injectable implant which is used for deep injection for soft tissue augmentation. It also aims to improve moderate to severe loss of jawline contour in adults over the age of 21. In addition, in January 2021, Merz Aesthetics, a medical aesthetics company with the largest dedicated medical aesthetic business in the world and Candela Corporation, a leading global medical aesthetic device company announced their collaboration to provide one of the broadest medical aesthetics portfolios across the globe. 

Author Name(s) : Linu Dash | Roshan Deshmukh
Frequently Asked Questions?

The top companies that hold the market share in dermal filler market are AbbVie Laboratories, Bioxis pharmaceutical, Cutera Inc., Elan aesthetics Inc., Galderma SA, Merz Pharma GmbH & Co. KGaA, Revance Therapeutics, Sinclair Pharma, Teoxane Laboratories, and Vital Esthetique Laboratories

Asia-Pacific is expected to register highest CAGR rom 2022 to 2031, owing to increase in number of geriatric female populations, rise in awareness among young population regarding aesthetics, and growth in healthcare expenditures

The key trends in the dermal filler market are rise in prevalence of early skin aging, and surge in demand for minimal invasive surgical procedure. In addition, increase in demand for dermal fillers procedure, increase in number of key players to offer different dermal fillers products and rise in number of product approvals by different key players

The base year for the report is 2021.

Yes, dermal filler companies are profiled in the report

The total market value of dermal filler market is $5,184.8 million in 2021.

The forecast period in the report is from 2022 to 2031

The market value of dermal filler market in 2022 was $5732.4 million

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Dermal Filler Market

Global Opportunity Analysis and Industry Forecast, 2021-2031